Dr. Monés assesses developments in geographic atrophy progression at the 6th Euretina Winter Meeting

__euretina_logo_2w_editora_2_110_1

Dr. Jordi Monés, the ophthalmologist specialising in macula, retina and vitreous and Medical Director of the Barcelona Macula Foundation: Research for Vision (BMF), assessed developments in geographic atrophy (GA) at the 6th Euretina Winter Meeting in Rotterdam on Saturday. GA is an advanced form of Age-Related Macular Degeneration (AMD).
Dr. Monés presented the study “Progression of GA” during the Complex Genetic Retinal Ophthalmology session, which was held at the Institut de la Màcula. This classified GA patients in different sub-groups, according to a method known as Cluster Analysis. These sub-groups were different in terms of disease progression and fundus characteristics, which is important for patient prognosis, optimal eligibility for clinical trials and phenotype-genotype correlations.


The seminar “Big data analysis and machine-based learning” linked to the EYE-RISK European project, in which the BMF played an active part, took place alongside the Congress. Drs. Jordi Monés and Marc Biarnés presented “Cluster analysis for GA phenotypes” and used the occasion to examine the study’s more technical aspects in greater detail.
The EYE-RISK project aims to identify risk factors, molecular mechanisms and therapeutic methods in the fight against AMD. It is an international research project with the participation of 8 research centres, 2 companies and a patients’ organisation from 6 European countries. EYE-RISK has received funding from the European Union’s Horizon 2020 programme, under Grant Agreement No. 634479.

   

Research is the only solution for the future to fight against blindness

It is only with your help that we can fight against blindness

Collaborate